EMA Pilots Partnering With Companies To Gain Efficiencies In Preparing Drug Assessment Reports

The European Medicines Agency is looking to increase the review efficiency and consistency of its assessors by experimenting with a US FDA-style approach in which companies can voluntarily submit certain information in advance to facilitate the product’s review.